68Ga-PSMA-11 PET-CT study in prostate cancer patients with biochemical recurrence and non-contributive 18F-Choline PET-CT: Impact on therapeutic decision-making and biomarker changes

Barbaud Matthieu; Frindel Mathieu; Ferrer Ludovic; Le Thiec Maelle; Rusu Daniela; Rauscher Aurore; Maucherat Bruno; Baumgartner Pierre; Fleury Vincent; Colombie Mathilde; Thierry-Morel Agnes; Kraeber-Bodere Francoise; Campion Loic; Rousseau Caroline

首页> 外文期刊>The Prostate >68Ga-PSMA-11 PET-CT study in prostate cancer patients with biochemical recurrence and non-contributive 18F-Choline PET-CT: Impact on therapeutic decision-making and biomarker changes

【24h】

68Ga-PSMA-11 PET-CT study in prostate cancer patients with biochemical recurrence and non-contributive 18F-Choline PET-CT: Impact on therapeutic decision-making and biomarker changes

机译：68GA-PSMA-11 PET-CT在前列腺癌中的生化复发患者和非促进18F-Choline PET-CT：对治疗决策的影响和生物标志物变化

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundIn this retrospective study, we investigated the impact of Ga-68-PSMA-11 PET-CT (PSMA PET-CT) upon the treatment plan and therapeutic response obtained for Prostate Cancer (PCa) patients presenting an occult biochemical recurrence.

机译：背景技术在此回顾性研究中，我们研究了GA-68-PSMA-11 PET-CT（PSMA PET-CT）对癌症癌症（PCA）患者获得的治疗计划和治疗反应的影响，所述癌症癌症患者潜水生化复发。

著录项

来源
《The Prostate》 |2019年第5期|共8页
作者
Barbaud Matthieu; Frindel Mathieu; Ferrer Ludovic; Le Thiec Maelle; Rusu Daniela; Rauscher Aurore; Maucherat Bruno; Baumgartner Pierre; Fleury Vincent; Colombie Mathilde; Thierry-Morel Agnes; Kraeber-Bodere Francoise; Campion Loic; Rousseau Caroline;
展开▼
作者单位

ICO Canc Ctr Nucl Med Unit St Herblain Pays De La Loir France;

ICO Canc Ctr Pharm Unit St Herblain Pays De La Loir France;

ICO Canc Ctr Phys Unit St Herblain Pays De La Loir France;

ICO Canc Ctr Nucl Med Unit St Herblain Pays De La Loir France;

ICO Canc Ctr Nucl Med Unit St Herblain Pays De La Loir France;

ICO Canc Ctr Pharm Unit St Herblain Pays De La Loir France;

ICO Canc Ctr Nucl Med Unit St Herblain Pays De La Loir France;

ICO Canc Ctr Pharm Unit St Herblain Pays De La Loir France;

ICO Canc Ctr Nucl Med Unit St Herblain Pays De La Loir France;

ICO Canc Ctr Nucl Med Unit St Herblain Pays De La Loir France;

ICO Canc Ctr Nucl Med Unit St Herblain Pays De La Loir France;

ICO Canc Ctr Nucl Med Unit St Herblain Pays De La Loir France;

Univ Nantes INSERM UMR1232 CRCINA CNRS ERL6001 Nantes Pays De La Loir France;

ICO Canc Ctr Nucl Med Unit St Herblain Pays De La Loir France;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类生物化学;
关键词
choline PET-CT; prostate cancer; PSMA PET-CT; recurrence; restaging;

机译：Choline Pet-CT;前列腺癌;PSMA PET-CT;复发;重新恢复;

相似文献

外文文献
中文文献
专利

1. 68Ga-PSMA-11 PET-CT study in prostate cancer patients with biochemical recurrence and non-contributive 18F-Choline PET-CT: Impact on therapeutic decision-making and biomarker changes [J] . Barbaud Matthieu, Frindel Mathieu, Ferrer Ludovic, The Prostate . 2019,第5期

机译：68GA-PSMA-11 PET-CT在前列腺癌中的生化复发患者和非促进18F-Choline PET-CT：对治疗决策的影响和生物标志物变化
2. [68Ga]Ga-PSMA-11 PET-CT: Local preliminary experience in prostate cancer biochemical recurrence patients [J] . Jo?o Carvalho, Pedro Nunes, Edgar Tavares da Silva, Archivio Italiano di Urologia e Andrologia . 2021,第1期

机译：[68Ga] Ga-PSMA-11 PET-CT：前列腺癌生化复发患者的局部初步经验
3. 68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning [J] . Jeremie Calais, Johannes Czernin, Minsong Cao, The Journal of Nuclear Medicine . 2018,第2期

机译：前列腺癌根治术后前列腺癌生化复发的68Ga-PSMA-11 PET / CT定位在PSA水平低于1.0 ng / mL的患者中：对挽救性放疗计划的影响
4. Combination of nuclear NF-κB/p65 localization and gland morphological features from surgical specimens is predictive of early biochemical recurrence in prostate cancer patients [C] . Patrick Leo, Eswar Shankar, Robin Elliott, SPIE Medical Imaging Conference . 2018

机译：手术标本的核NF-κB/ p65定位和腺体形态学特征的结合预示着前列腺癌患者的早期生化复发
5. Development of an immuno-mass spectrometric assay for validation of protein C inhibitor (PCI) as a biomarker for prediction of biochemical recurrence in prostate cancer patients [D] . Razavi, Morteza 2012

机译：开发一种用于鉴定蛋白C抑制剂（PCI）作为预测前列腺癌患者生化复发的生物标记物的免疫质谱法
6. 68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning [O] . Jeremie Calais, Johannes Czernin, Minsong Cao, -1

机译：前列腺癌根治术后前列腺癌生化复发的68Ga-PSMA-11 PET / CT定位在PSA水平低于1.0 ng / mL的患者中：对挽救性放疗计划的影响
7. Impact of 68Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence [O] . Jeremie Calais, Wolfgang P. Fendler, Matthias Eiber, 2017

机译：68GA-PSMA-11 PET / CT对生物化学复发癌前列腺癌患者的影响

68Ga-PSMA-11 PET-CT study in prostate cancer patients with biochemical recurrence and non-contributive 18F-Choline PET-CT: Impact on therapeutic decision-making and biomarker changes

摘要

著录项

相似文献

相关主题

期刊订阅